Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
kr131.78 Mil
% of Total Estimate Gain
65.84%

MoA International Fund's Novo Nordisk AS Holding Summary

As of 2025-03-31, MoA International Fund held - shares of Novo Nordisk AS(OCSE:NOVO B), totaling N/A. This investment constitutes 0% of their stock portfolio, and MoA International Fund now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.

The initial trade took place in 2022Q1. And since then MoA International Fund has made 2 purchases of OCSE:NOVO B, at an average price of kr365.37, for a total of 547,776.00 shares. In addition, there have been 4 sales at an average price of kr605.94 for 547,776.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr451.30, MoA International Fund's estimated gain on his OCSE:NOVO B holdings is kr131.78 Mil, reflecting a 65.84% gain to date.

MoA International Fund OCSE:NOVO B (kr451.30) Holding Chart

MoA International Fund OCSE:NOVO B (kr451.30) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price kr-/Share
Shares Sold 0 Average Price kr-/Share
Current Price kr0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1